Publications

TitleAbstractYear
Filter
PMID
Filter
us anthrax-vaccine producer saved for now. 19989500344
use of anthrax vaccine in the united states: recommendations of the advisory committee on immunization practices.these recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (anthrax vaccine adsorbed [ava], bioport corporation, lansing, mi) in the united states for protection against disease caused by bacillus anthracis. in addition, information is included regarding the use of chemoprophylaxis against b. anthracis.200111327233
optimistic bias and perceptions of bioterrorism in michigan corporate spokespersons, fall 2001.the notion that individuals believe that they are more likely than others to experience positive events and avoid negative ones is a well-documented phenomenon in the combined literatures of social psychology and health communication. the current study focuses on michigan corporate spokespersons' perceptions of their company's risk and potential for optimistic bias. beginning on september 10, 2001, and continuing through october 2001, telephone surveys were conducted by a professional survey res ...200314692582
syndromic analysis of computerized emergency department patients' chief complaints: an opportunity for bioterrorism and influenza surveillance.emergency department computerized triage logs might be useful for automated ed surveillance and potentially for early identification of bioterrorism events. we describe a web-based surveillance program and its feasibility for surveillance.200312658241
use of anthrax vaccine in the united states.these recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (anthrax vaccine adsorbed [ava], bioport corporation, lansing, mi) in the united states for protection against disease caused by bacillus anthracis. in addition, information is included regarding the use of chemoprophylaxis against b. anthracis.200011145529
surveillance for adverse events associated with anthrax vaccination--u.s. department of defense, 1998-2000.concerns about the potential use of anthrax as a biologic weapon prompted the u.s. department of defense (dod) to announce on december 15, 1997, anthrax vaccination of all u.s. military personnel. this effort is coordinated by the anthrax vaccine immunization program (avip). avip plans a phased vaccination process to achieve total force protection against anthrax by 2004. the current phase of implementation includes vaccination of all service members and mission-essential dod civilian employees ...200010817479
Displaying items 1 - 6 of 6